Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Cardiol. Mar 26, 2024; 16(3): 149-160
Published online Mar 26, 2024. doi: 10.4330/wjc.v16.i3.149
Figure 1
Figure 1 The study flow diagram. HFrEF: Heart failure with reduced ejection fraction; HFmrEF: Heart failure with mid-range ejection fraction; MRI: Magnetic resonance imaging.
Figure 2
Figure 2 Epicardial adipose tissue image. A: Volume measurement of epicardial adipose tissue outlining the contours of the myocardium in short-axis images of end-diastole; B: The visceral pericardium (green line), myocardium (red line) and the parietal (blue line) in the same short-axis image; C: EAT: Epicardial adipose tissue (laurel-green area).
Figure 3
Figure 3 Comparison of different epicardial adipose tissue parameters in obese population with and without heart failure with preserved ejection fraction. A: Epicardial adipose tissue volume group; B: Epicardial adipose tissue index group; C: Epicardial adipose tissue mass group; D: Epicardial adipose tissue mass index group; E: Epicardial adipose tissue/left atrial left-right diameter ratio group. EAT: Epicardial adipose tissue; LA: Left atrial; LR: Left-right diameter; HFpEF: Heart failure with preserved ejection fraction.